Evidence map›Paper›PMID 32269085›Full record

ArticleThe European respiratory journal2020

Pathogenesis of COVID-19 from a cell biology perspective.

Robert J Mason

2 registry-linked trialsAbstract readEditorial
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 419 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
419citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04631536 phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at the Lebanese American University Medical Center- Rizk Hospital

TypeinterventionalSponsorLebanese American University Medical CenterRan2021 to 2022Enrolled42ConditionsCovid19ArmsAtorvastatin + L-arginine + Folic acid + Nicorandil + Nebivolol, Placebo
NCT04922814 nacompletednot on this mapstarted 2021, after this paper: background citation

Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

TypeinterventionalSponsorAssiut UniversityRan2021 to 2022Enrolled40ConditionsCOVID-19 Acute Respiratory Distress Syndrome, Sedation Complication, ICU Acquired WeaknessArmsmuscle relaxation
3 · Its place in the literature

Who cites it

419 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pediatric endocrinopathies related to COVID-19: an update.World journal of pediatrics : WJP · 2023
    Pooled it
  2. Innate immunity to SARS-CoV-2 infection: a review.Epidemiology and infection · 2022
    Pooled it
  3. Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

359 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert J MasonNational Jewish Health, Dept of Medicine, Denver, CO, USA masonb@njhealth.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asymptomatic InfectionsBetacoronavirusCoronavirus InfectionsCOVID-19Disease ProgressionEpithelial CellsHumansPandemicsPneumonia, ViralRespiratory SystemSARS-CoV-2

Identifiers

PMID32269085
PMCPMC7144260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.